Kissei Pharmaceutical Co Stock Performance
| KSPHF Stock | USD 26.97 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.87, which conveys possible diversification benefits within a given portfolio. Kissei Pharmaceutical returns are very sensitive to returns on the market. As the market goes up or down, Kissei Pharmaceutical is expected to follow. At this point, Kissei Pharmaceutical has a negative expected return of -0.0855%. Please make sure to verify Kissei Pharmaceutical's standard deviation, as well as the relationship between the maximum drawdown and day median price , to decide if Kissei Pharmaceutical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Kissei Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Kissei Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 43.4 B | |
| Total Cashflows From Investing Activities | 10.8 B |
Kissei |
Kissei Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 3,028 in Kissei Pharmaceutical Co on September 30, 2025 and sell it today you would lose (331.00) from holding Kissei Pharmaceutical Co or give up 10.93% of portfolio value over 90 days. Kissei Pharmaceutical Co is currently producing negative expected returns and takes up 4.481% volatility of returns over 90 trading days. Put another way, 40% of traded pink sheets are less volatile than Kissei, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Kissei Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kissei Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Kissei Pharmaceutical Co, and traders can use it to determine the average amount a Kissei Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0191
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KSPHF |
Based on monthly moving average Kissei Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kissei Pharmaceutical by adding Kissei Pharmaceutical to a well-diversified portfolio.
Kissei Pharmaceutical Fundamentals Growth
Kissei Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Kissei Pharmaceutical, and Kissei Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kissei Pink Sheet performance.
| Return On Equity | 0.0648 | |||
| Return On Asset | -0.0017 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 487.73 M | |||
| Shares Outstanding | 46.12 M | |||
| Price To Earning | 15.20 X | |||
| Price To Book | 0.58 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 65.38 B | |||
| EBITDA | 20.26 B | |||
| Cash And Equivalents | 49.24 B | |||
| Total Debt | 1.64 B | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 4,246 X | |||
| Cash Flow From Operations | 1.53 B | |||
| Earnings Per Share | 1.74 X | |||
| Total Asset | 238.09 B | |||
About Kissei Pharmaceutical Performance
By analyzing Kissei Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Kissei Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Kissei Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Kissei Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products primarily in Japan. The company was founded in 1946 and is headquartered in Matsumoto, Japan. Kissei Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1828 people.Things to note about Kissei Pharmaceutical performance evaluation
Checking the ongoing alerts about Kissei Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Kissei Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kissei Pharmaceutical generated a negative expected return over the last 90 days | |
| Kissei Pharmaceutical has high historical volatility and very poor performance | |
| Kissei Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
| About 26.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Kissei Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kissei Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Kissei Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kissei Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kissei Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kissei Pharmaceutical's pink sheet. These opinions can provide insight into Kissei Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Kissei Pink Sheet analysis
When running Kissei Pharmaceutical's price analysis, check to measure Kissei Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kissei Pharmaceutical is operating at the current time. Most of Kissei Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Kissei Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kissei Pharmaceutical's price. Additionally, you may evaluate how the addition of Kissei Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |